Lumpinas, Baby Boy .
HRN: 29-12-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2026
AMPICILLIN 250MG (VIAL)
06/07/2026
06/13/2026
IVT
140mg
Q12H
PSNB (PROM X 52 Hours; Thickly MSAF)
Pending Pharmacy Acceptance
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: